Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis?
ClinicalTrials.gov study NCT03618212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03793907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07221032. IPD Sharing: NO. Countries: 1. Publications: 0.
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
ClinicalTrials.gov study NCT04211259. IPD Sharing: NO. Countries: 1. Publications: 0.
Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
ClinicalTrials.gov study NCT06461988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07249073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma
ClinicalTrials.gov study NCT00327314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT06048250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Borte
ClinicalTrials.gov study NCT04790474. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06055075. IPD Sharing: YES. Countries: 6. Publications: 0.
Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma
ClinicalTrials.gov study NCT06041698. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide for Multiple Myeloma
ClinicalTrials.gov study NCT00038233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01168804. IPD Sharing: Not stated. Countries: 2. Publications: 0.
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06279026. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
ClinicalTrials.gov study NCT03106324. IPD Sharing: NO. Countries: 12. Publications: 0.
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
ClinicalTrials.gov study NCT06154902. IPD Sharing: NO. Countries: 1. Publications: 0.
Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT04933539. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01758328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03860038. IPD Sharing: NO. Countries: 2. Publications: 0.
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
ClinicalTrials.gov study NCT04680468. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.